Cyclin B2 is a regulator of p34cdc2 kinase, involved in G2/M progression of the cell cycle, whose gene is strictly regulated at the transcriptional level in cycling cells. The mouse promoter was cloned and three conserved CCAAT boxes were found. In this study, we analysed the mechanisms leading to activation of the cyclin B2 CCAAT boxes: a combination of (i) genomic footprinting, (ii) transfections with single, double and triple mutants, (iii) EMSAs with nuclear extracts, antibodies and NF-Y recombinant proteins and (iv) transfections with an NF-YA dominant negative mutant established the positive role of the three CCAAT sequences and proved that NF-Y plays a crucial role in their activation. NF-Y, an ubiquitous trimer containing histone fold subunits, activates several other promoters regulated during the cell cycle. To analyse the levels of NF-Y subunits in the dierent phases of the cycle, we separated MEL cells by elutriation, obtaining fractions 480% pure. The mRNA and protein levels of the histone-fold containing NF-YB and NF-YC were invariant, whereas the NF-YA protein, but not its mRNA, was maximal in mid-S and decreased in G2/M. EMSA con®rmed that the CCAAT-binding activity followed the amount of NF-YA, indicating that this subunit is limiting within the NF-Y complex, and suggesting that post-transcriptional mechanisms regulate NF-YA levels. Our results support a model whereby ®ne tuning of this activator is important for phase-speci®c transcription of CCAATcontaining promoters.
Introduction
Cyclins are a family of proteins that control cell division, by regulating the activity of a set of proteinkinases that dictate transitions in the dierent phases of the cell-cycle (for review, see Peter and Herskovitz, 1994) . Alterations in the levels of speci®c cyclins are associated with the development of human tumours: cyclin D1 in small cell lung and mammary carcinomas (Wang et al., 1994) , cyclin E in mammary tumours (Buckley et al., 1993; Keyomarsi and Pardee, 1993; . Gong et al., 1994) , cyclin A in hepatocellular carcinomas (Wang et al., 1990) cyclin B1 in leukemias and solid tumours (Gong et al., 1994) . Type-B cyclins (B1, B2, B3) activate p34cdc2 kinase, thus controlling G2/M transition (for review, see Kishimoto and Okamura, 1997) . In growing cells, one important level of control is the timely cell cycle dependent transcriptional regulation of the genes coding for regulatory proteins. In general, genes whose products control cellcycle regulatory pathways show a remarkable variation in their expression during the cell cycle. Cyclin A and CDC2 genes, for example, are expressed in the G1/S transition; during the S phase, the promoters whose genes are necessary for DNA replication become active: circuits leading to their expression require crucial factors of the E2F/DP family (Lam and La Thangue, 1994) : their highly regulated dissociation from controlling proteins, such as the antioncogene RB product, have been studied in details (Herwig and Strauss, 1997) . Subsequently, the genes of CDC25C and cyclins B1, B2, are up-regulated transcriptionally in late S (Muller, 1995; Piaggio et al., 1995; Brandeis and Hunt, 1996) . The mechanisms leading to gene activation of G2/M genes are less well understood than those of S phase genes, but recent studies performed on the CDC25C promoter indicate that both repressive and activating mechanisms are operational; such complexity is shared by E2F1, cyclin A and CDC2 genes (Hsiao et al., 1994; Johnson et al., 1994; Zwicker et al., 1995a,b) . From the analysis of promoters of cell cycle regulatory genes, common structural features are emerging: a low frequency of TATA boxes, and the presence of GC and/or CCAAT boxes, recognized by SP1 and NF-Y, respectively (for review, see . The cell-cycle control is generally exerted by elements of the proximal promoter, often by boxes very close to the start site(s) and distant enhancer elements are generally not in¯uential. Several such promoters contain multiple NF-Y-binding CCAAT boxes close to the Cap site; among them, the cyclin B1 has two and CDC25C has three such CCAAT, that are required for transcriptional regulation (Zwicker et al., 1995a,b; Katula et al., 1997; Farina et al., in press ).
NF-Y (CBF) is an heteromeric protein composed of three subunits, NF-YA, NF-YB and NF-YC, all necessary for DNA-binding (for reviews, see Mantovani, 1998; Maity and deCrombrugghe, 1998) . NF-YB and NF-YC tight association is a prerequisite for NF-YA binding and sequence-speci®c DNA interactions. NF-YA and NF-YC have large (180 amino acids) Qrich activation domains. Both NF-YB and NF-YC conserved domains contain putative histone fold motifs (Baxevanis and Landsman, 1998) . This motif, common to all core histones, is composed of three a-helices separated by short loops/strand regions, enabling histones to dimerize with companion subunits, to form the histone octamer. Histone folds are shared by other proteins involved in transcriptional regulation, such as the TBP-binding transcriptional repressor NC2 (Inostroza et al., 1992; Goppelt et al., 1996; Mermelstein et al., 1996) and some of the TAF II s (for review, see Burley and Roeder, 1996) . Consistent with these structural characteristics, NF-Y has been shown to impart a high level of three dimensional organization to the twin CCAAT boxes region of the human gglobin promoter (Liberati et al., 1998) . In accordance with the widespread presence of CCAAT boxes, NF-Y subunits are extremely conserved and have been identi®ed in many eukaryotic kingdoms; in mammals, NF-Y has been found in essentially all cell types, suggesting that it represents a prototypic example of the immutable, constitutive transcription factor. However, recent ®ndings with non-immortalized IMR90 lung ®broblasts and human macrophages challenge this vision, since changes in the levels of the CCAATbinding activity have been described (Chang and Liu, 1994; Good and Chen, 1996; Marziali et al., 1997) . After isolation of the mouse cyclin B2 promoter region (Brandeis and Hunt, 1996) , we employed a combination of genomic footprinting, EMSA (Electrophoretic Mobility Shift Assay) and transfection approaches to identify NF-Y as the cyclin B2 CCAAT boxes activator. We further studied the cell-cycle regulation of all three NF-Y subunits both at the protein and mRNA levels.
Results

In vivo footprinting of the cyclin B2 promoter
To understand the molecular mechanisms underlying the regulation of the cyclin B2 gene, we cloned and characterized its mouse promoter, whose core sequence is outlined in Figure 1a : two major transcriptional start sites were identi®ed (Brandeis and Hunt, 1996) and transfection studies con®rmed that a 1.1 Kb genomic fragment 5' of the transcriptional start sites confers cell-cycle regulation to an heterologous gene in a manner that mimicks closely the in vivo expression of the cyclin B2 gne (CL-z D, KE, unpublished) . A notable feature of this promoter is the absence of a TATA box, and the presence of multiple CCAAT boxes (Y1, Y2, Y3) a common ®nding among cell-cycle regulated promoters (see . We initially performed genomic footprinting in vivo in this core promoter region. The identi®cation of nucleotides that are protected from DMS, presumably because of binding of relevant DNA-binding proteins, is a very successful approach in pinpointing important regulatory elements. By using appropriate primers, we LM ± PCR ampli®ed from DMS-treated mouse myo- Figure 1 In vivo footprinting of the cyclin B2 promoter in C2C12 cells. The sequence of the mouse cyclin B2 promoter is outlined in (a) and in vitro DMS-treated DNA is run parallel with LM ± PCR of DNA derived from C2C12 treated in vivo with DMS (b). CCAAT elements are boxed and indicated as Y1, Y2, Y3. Nucleotides on the bottom strand that are completely (full arrows) or partially (dotted arrows) protected are indicated. The two major transcriptional start sites described by Brandeis and Hunt (1996) are represented by big arrows. The +6/+8 protections correspond to a CDE-like sequence blasts an area comprised between 797 and +200, which contains the three conserved CCAAT elements and the supposed CDE-like sequence. Figure 1b shows the result of such experiment: several nucleotides are strongly and consistently protected: in particular, two Gs at pos. 779, 778 and at pos. 746, 745, corresponding to the Y1 and Y2 CCAAT boxes, and the Gs of the proximal Y3 CCAAT at pos. 712, 713, 714 appear also to be signi®cantly decreased in intensity. In addition, the G at 767 between Y1 and Y2, and, more downstream, CDE-like sequences in the transcribed region are also protected (for a summary of results, see Figure 1a ).
Functional importance of the CCAAT boxes
Results from the previous experiments indicate that the CCAAT boxes of the cyclin B2 promoter are recognized by transcription factors in vivo. To determine their functional importance, we inserted 1.1 Kb of the cyclin B2 upstream sequences in front of a Luciferase reporter gene. Transfections of NIH3T3 ®broblasts yielded high levels of luciferase activity compared to the control promoter-less vector (KE, in preparation), proving that transcriptional regulatory sequences are indeed present in the B2-Luci construct. Then, we mutated the core CCAAT pentanucleotide to TTACT, either singularly (Y1m, Y2m and Y3m in tandem Y1,2m, Y1,3m and Y2,3m) or in all Y1,2,3m CCAAT boxes. These constructs were transiently transfected in proliferating NIH3T3 and normalized to a second Luciferase from Renilla. Activity of mutants B2-Luci constructs were compared to the wt B2-Luci positive control (Figure 2 ). All three single CCAAT mutants appear to contribute to transcription, as their activities are all down: the most crippled is the Y3m at 36% of wt activity. Similar is the loss of Y1m activity, while reduction of Y2 is less dramatic. Double mutants con®rm the importance of Y1, with Y1,2 showing the lowest levels of expression of all mutants. The basal CCAAT-less promoter activity of the Y1,2,3 mutant is approximately 30% compared to the wt construct. Transcriptional activity drops below the 45% level with nearly all combinations, the only exception being the single Y2m. Thus, the triple CCAAT sequences account for more than two-thirds of the total promoter activity. We conclude that changes in the consensus CCAAT of the three sites aect transcription of the cyclin B2 promoter to a signi®cant degree, with Y1 and Y3 being the focus of the strongest positive regulation. Altogether, these functional data are in good agreement with the in vivo footprinting analysis, in that CCAAT-bound proteins are important for B2 regulation and indicate that activation due to single CCAAT is not cumulative: if integrity of the Y1 or Y3 site is lost, the B2 promoter is essentially CCAAT-less, as mutations of more sites have comparatively less eect.
NF-Y binds Cyclin B2 Y1 and Y2 CCAAT boxes
Given the importance of CCAAT boxes, it was important to determine the identity of the transcription factor(s) binding to them. We ®rst used the Electrophoretic Mobility Shift Assay (EMSA) with a long oligonucleotide encompassing the two most protected in vivo Y1 and Y2 boxes. Incubation of such labelled fragment with increasing amounts of nuclear extracts from exponentially growing cell lines (mouse ®broblasts LMTK extracts are shown in Figure  3a ) yielded two major shifted complexes migrating close to each other ( Figure 3a , lanes 1, 4, 7, 10 and 13). Competition with an unlabelled homologous oligonucleotide ( Figure 3a , lanes 2, 5, 8, 11 and 14), but not with an irrelevant one (a TATA-Box oligonucleotide, see Figure 3a , lanes 3, 6, 9, 12 and 15), prevented formation of these retarded bands, thus indicating that they are due to speci®c DNA-binding proteins. These complexes were also observed with Hela extracts and competed with shorter oligonucleotides containing Y1 or Y2, but not with mutated versions of the latter, suggesting that the CCAAT elements were responsible for binding (not shown). Although dierent proteins were reported to bind CCAAT-related sequences, only the trimeric NF-Y/CBF factor is known to absolutely require this pentanucleotide (see Mantovani, 1998; Maity and deCrombrugghe, 1998) . A close inspection of the three B2 CCAAT sequences suggested that Y1 and Y2 are consensus NF-Y binding sites; less so Y3, because of the presence of Ts both at 71 and +8 positions with respect of the ®rst C of the CCAAT pentanucleotide, a rare event among high anity NF ± Y sites (Mantovani, 1998) . We then used the puri®ed rabbit polyclonal antibodies raised in our lab against the A and B NF-Y subunits to ascertain whether the complexes generated on the double CCAAT oligonucleotide are related to NF-Y; these antibodies are highly speci®c and detected NF-Y complexes on many dierent sites (Mantovani, 1998) . Such EMSA is shown in Figure 3b : dierent doses of anti-NF-YA (lanes 1 and 2), anti-NF-YB (lanes 3 and 4) and of the newly derived anti-NF-YC (lanes 5 and 6) antibodies supershifted the major bands formed on the Y1-Y2 oligonucleotide, while an irrelevant anti-lysozime polyclonal had no eect (lane 7). This experiment identi®ed NF-Y as the CCAAT-binding protein.
To detail the binding anity of the B2 CCAAT boxes, we used recombinant NF-Y produced and puri®ed from E. coli and a labelled oligonucleotide containing the high anity MHC class II Ea Y box: Figure 4a . The distal Y1 eciently competed at the lowest dose (2 ng, see lanes 2 ± 4), the Y2 also reduced binding, but at higher concentration (lanes 5 ± 7), whereas the Y3 was eective only at 50 ng oligonucleotide concentration (lanes 8 ± 10). To con®rm these results, we used recombinant NF-Y with the Y1-Y2 oligonucleotide: in Figure 4b , two bands are indeed formed, resulting from single CCAAT occupancies the lower complex (and from simultaneous Y1 and Y2 binding) the upper complex (Figure 4b, lane 1) ; both are competed eciently by the cold Y1-2 oligonucleotide ( Figure 4b , lanes 2 ± 4), Y1 (Figure 4b , lanes 5 ± 7) and Y2, although the latter competed less eciently the lower complex (Figure 4b , lanes 8 ± 10). Taken together, these data prove that NF-Y is the major DNA-binding activity detected in EMSA with nuclear extracts and that it binds to the three CCAAT with dierent anities: Distal Y14Middle Y24Proximal Y3.
NF-Y is required for cyclin B2 CCAAT boxes function
The results presented so far strongly suggest that NF-Y is the B2 CCAAT activator. To unambiguously prove this point, we used the dominant negative NF-Y vector (YA13m29) developed in our lab (Mantovani et al., 1994) : upon transfections in mammalian cells, it expresses a mutant protein containing a triple aminoacids substitution in the NF-YA DNA-binding subdomain that still enables the subunit to interact with the NF-YB-NF-YC dimer, but renders the resulting trimer inactive in terms of CCAAT recognition. This vector is highly diagnostic, as it has been tested in many dierent systems and shown to be speci®c for NF-Y-dependent promoters (Jackson et al., 1995; Lu and Yen, 1996; Kim et al., 1997; Ericsson et al., 1997; Marziali et al., 1997; Eggers et al., 1998; Liu et al., 1998; Jin and Scotto, 1998; Farina et al., in press ). We cotransfected NIH3T3 cells with the B2-Luci vector, together with increasing amounts of YA13m29: Figure 5 shows that the dominant negative vector is indeed inhibitory, starting at 300 ng doses. At higher doses, B2-Luci transcription was down threefold, a level that ®ts well with the relative contribution of the three NF-Y-binding CCAAT boxes, as tested in transfections with CCAAT mutants (see Figure 2) . Control experiments were also performed to verify the speci®city of the dominant negative eect, by cotransfecting it with the Y1, Y2 mutant: in these experiments, the YA13m29 did not have any signi®cant negative eect (Figure 5b ). These data establish NF-Y as the CCAAT-boxes activator of cyclin B2 transcription.
Cell-cycle regulation of NF-Y subunits
Because of the role played by NF-Y in cyclin B2 transcription, and in the activation of several other cell-cycle regulated promoters, we sought to quantify the levels of NF-Y binding activity and the expression of the single subunits during the cell cycle. To this aim, we separated exponentially growing mouse MEL cells by elutriation, so that nearly homogeneous (480% pure) populations for each phase of the cell cycle could be analysed. A typical FACS pro®le of the elutriation is shown in Figure 6a : extracts were prepared from fractions 5 ± 15, quanti®ed for protein concentration by Bradford and tested in EMSA, ®rst for CREB binding activity, a DNA-binding protein known to be invariant during the cell-cycle (Desduoets et al., 1995) . Figure 6b shows that no obvious dierence is observed in extracts from fractions corresponding to the dierent phases. In parallel, they were assayed for CCAAT-binding with Ea Y box oligonucleotide: activity was high and relatively constant throughout G1 and S, peaking in mid-S, while considerably less binding was detected in G2/M fractions (Figure 6b , see fractions 13 ± 15). Since NF-Y is a trimer, this eect could be due to one or two of the subunits, or to a parallel modulation of all three. To discriminate between these possibilities, we analysed protein levels of all NF-Y subunits by Western blots with the already described anti-YA and anti-YB antibodies and with the newly derived anti-YC. The lower panel in Figure 6b indicates that NF-YC and NF-YB are remarkably constant (albeit a small drop in NF-YB is observed in G2/M fractions) while the level of NF-YA follows well the NF-Y binding activity, being considerably lower in G2/M fractions and highest in mid-S (compare fractions 10 and 15 in Figure 6b ). Note that NF-YA was previously shown to be composed of two major forms (45 and 41 kD) due to tissue-speci®c splicing in the Q-rich activation . In MEL cells the short 41 kD form predominates and the long 45 kD form is visible only in S phase fractions: thus modulation of the two forms appears to be parallel. On the other hand, determination of the NF-YA mRNA levels by Northern blot clearly indicated that they are remarkably constant in all phases of the cell-cycle (Figure 6c ). As one could have anticipated from Western blot analysis, the same is also true for NF-YB and NF-YC mRNAs (data not shown). Taken together these data prove that (i) the NF-Y binding activity is regulated during the cell cycle, (ii) this is due to the variation of NF-YA levels and (iii) this is obtained by a post-transcriptional mechanism.
Discussion
In this report we focused our attention on the three cyclin B2 promoter CCAAT boxes: functional experiments proved that they are all important for optimal transcription, and genomic footprinting detected partial (Y3) and complete (Y1 and Y2) protections, a clear indication of transcription factors binding in vivo.
EMSAs and transfections with a dominant mutant established that the ubiquitous CCAAT-binding trimer NF-Y is involved in cyclin B2 activation. Finally, we systematically investigated the mRNA and protein levels of all NF-Y subunits during the cell cycle and found that while the histone fold subunits are invariant, NF-YA dictates the CCAAT-binding activity, through mechanisms that involve post-transcriptional regulation.
Cell-cycle regulation of NF-Y
A novel important ®nding of the present study is that the levels of the NF-Y binding activity are far from being constant throughout the cell cycle: in particular, they are maximal in mid-S and considerably lower in G2/M. It should be noted that because of the separation system that we employed, we are unable to say whether this decrease is in G2 or M, or in both. Variations are due to the NF-YA subunit. This is somewhat surprising, given the high conservation of the three subunits (yeast, parasites, plants, mammals) and their ubiquitous presence in all cell lines: a result in line with the statistically proven presence of NF-Y sites in 25% of eukaryotic promoters, including housekeeping, tissue-speci®c, inducible and cell-cycle regulated. On the other hand, our data on the cell cycle regulation of the NF-YA subunit ®t well with recent studies performed in three systems: (i) in IMR90 lung ®broblasts, NF-Y decreases upon serum deprivation and cell senescence (Chang and Liu, 1994; Good and Chen, 1996) ; (ii) in human peripheral macrophages, the levels of NF-YA (and of CCAAT-binding activity in EMSA) increase dramatically upon dierentiation, with no signi®cant quantitative change in mRNA (Marziali et al., 1997; Marziali et al., in press ); (iii) in C2C12 myoblasts, disappearance of CCAAT-binding activity upon terminal dierentiation to myotubes is due to lack of NF-YA in the presence of substantial, albeit reduced, levels of NF-YA mRNA (Farina et al., in press) . In all such examples, NF-YA protein levels are responsible for NF-Y modulation; in the two latter systems, both NF-YB and NF-YC proteins, as well as their mRNAs have been proven to remain invariant (Marziali et al., in press; Farina et al., in press ). We conclude, therefore, that post-transcriptional control is one major way to regulate NF-YA protein levels and hence CCAAT-binding activity. This could be accomplished either by control of translation, or by protein degradation. The ®rst mechanism is suggested by the ®nding that NF-YA has a stunningly invariant 5' UTR: over 95% sequence identity among human, mouse and chicken over 80 nucleotides, higher than in the coding sequences (RM, unpublished). On the other hand, cell cycle control of regulatory proteins often involves protein degradation, through the ubiquitin system for example. Investigations aimed at clarifying these points are underway.
Opposite to NF-YA, the NF-YB/NF-YC subunits are remarkably invariant in all conditions tested so far, both at the mRNA and protein levels; this parallel invariance con®rms previous biochemical data showing that NF-YB and NF-YC act as inevitable partners and can be found biochemically separated from NF-YA (Bellorini et al., 1997) . Moreover, their invariance, their involvement in high molecular weight protein complexes and their histone-like nature strongly suggest that they play additional, structural roles in gene activation. In conclusion, NF-Y is composed of two constant housekeeping subunits, and one (NF-YA) which appears to be the regulatory subunit, at least in terms of CCAAT recognition.
Activation of CCAAT-containing cell-cycle regulated promoters
The data presented here on the activation of cyclin B2 CCAAT boxes are reminiscent of two G2/M speci®c promoters: (i) the cyclin B1 promoter has two NF-Y sites separated by 33 bp, overlapping the two major transcriptional start sites (Katula et al., 1997) : this short region was shown to mediate activation in proliferating C2C12 cells and switch o in differentiated cells (Farina et al., in press ). However, unlike the experiments with the Y1, Y2 and Y3 single mutants shown here, mutations of either B1 CCAAT did not aect transcription, while elimination of both had a more profound eect than the triple B2 mutant assayed in this study; (ii) the CDC25C promoter has three Y boxes in the reverse orientation, spaced by 33 and 31 bp, with suboptimal binding anities, particularly the distal Y3 (Zwicker et al., 1995a, b) ; taken singularly, they are not able to activate, but when combined they are highly active, either in the context of the natural CDC25C, or of the heterologous SV40 promoters. These ®ndings suggest that multiple NF-Y sites are indeed able to synergize among them, not only with neighbouring enhancer elements. With this line of reasoning, the discrepancy of Y3, which binds NF-Y with low anity, yet it contributes more than the higher anity Y1 and Y2, can be explained by formulating two hypotheses: the ®rst is that another protein dierent from NF-Y speci®cally recognizes the Y3 CCAAT sequence and is involved in activation. We do not favour this, since to date no other protein has been convincingly shown to bind to this pentanucleotide and Y3 does not have palyndromic consensus sequences recognized by C/EBP or NFI (Mantovani, 1998) , two proteins whose binding sites occasionally overlap a CCAAT box. The second hypothesis assumes that Y3 requires Y1 and Y2, whose in vivo occupancy is the strongest, for stable NF-Y binding: indeed when the latter are mutated, transcription is at the lowest level, presumably because Y3 is unable to contact NF-Y when isolated from Y1-Y2. In this scenario, NF-Y binding to Y3, which is closest to the start site and to the in vivo protected CDE-like sequence, might serve the fundamentally dierent role of an eector protein rather than a structural one (see scheme in Figure 7) . In this context, the cell-cycle variations of the NF-Y trimer described here might have a more profound eect on the weaker site and by altering crucial interactions with the basal machinery, or with the nearby controlling elements, promoter strength could be remarkably modulated.
NF-Y has been shown to be directly involved in binding to several cell cycle regulated promoters (Chang and Liu, 1994; Filatov and Thelander, 1995; Huet et al., 1996; Isaacs et al., 1996; Katula et al., 1997; Liu et al., 1998; van Ginkel et al., 1997; Uchiumi et al., 1997) and in many cases, CCAAT boxes are very close to, or overlapping, elements conferring cell cycle control: (i) the E2F1 promoter is activatd in a strict G1/S-phase dependent way through an E2F site, whose mutation leads to derepression in G0 (Hsiao et al., 1994; Johnson et al., 1994) ; the group of P Farnham has further shown that S phase speci®c E2F-mediated activation of E2F1 preferentially requires cooperation with the natural NF-Y binding site (van Ginkel et al., 1997) ; (ii) in the cyclin A, CDC25C and CDC2 promoters, NF-Y binding sites are close to the CDE-CHR sequences that control phase-speci®c transcription (Zwicker et al., 1995a, b) ; (iii) several studies found that NF-Y is a key activator of promoters active in G1/S boundary, such as TK (Chang and Liu, 1994; Kim et al., 1997) . Thus promoters active in all phases of the cycle are shown to require NF-Y: G1/S, S, S/G2, G2/M. Although CCAAT boxes of several promoters are in vivo footprinted in all phases of the cell-cycle (Zwicker et al., 1995a, b; Huet et al., 1996) , nearby phase-speci®c controlling elements, such as the CDE-CHR, mediate repression only if NF-Y sites are present (Zwicker et al., 1995b) . Moreover, experiments with Gal4 constructs indicate that CDF-1, a CDEbinding protein, is able to repress transcription by speci®cally targeting, among others, the NF-YA Q-rich activation domain (Liu et al., 1997; . Our ®nding that NF-Y binding activity varies signi®cantly during the cell cycle adds yet another level of complexity in the control of CCAAT-containing cell-cycle regulated promoters. G2/M promoters, such as Cyclin B1, B2, CDC25C and PLK, are active when the CCAAT binding activity is minimal: this apparent discrepancy can be reconciled considering that (i) the overall number of CCAAT-containing promoters active in late phases is considerably simply lower, thus requiring less CCAAT-binding activity for their activation; (ii) Transcription ensues in late S, when NF-YA levels are high. It should be noted, however, that NF-Y binding levels are high throughout G1 and early S phases, in which the B2 gene is silent: thus additional yet unidenti®ed elements are most likely contributing to the cell cycle regulation of this promoter.
In summary, because of the frequencies and arrangements of its binding sites, their peculiar position and functional importance, the apparently special connections with diverse phase-speci®c regulators binding nearby, and its cell-cycle variation, NF-Y should be considered as a pivotal player in cell-cycle transcriptinal regulation. Additional protein-protein interactions experiments among NF-Y molecules, and with other activators and repressors, should shed light on the molecular mechanisms leading to ®ne tuning of gene expression of crucial cell cycle regulatory genes.
Materials and methods
In vivo genomic footprinting
Proliferating C2C12 cells were treated with 0.1% DMS for 30 s. After DMS treatment, cells were washed three times with cold phosphate-buered saline (PBS). DNA was isolated and cleaved with piperidine. As a control, C2C12 genomic DNA was methylated in vitro with 0.125% DMS for 2 min. Genomic footprinting was performed by using LM ± PCR as described (Dey et al., 1992) . The following oli-gonucleotides were used as primers: ®rst primer, Tm=47, 648C: 5'-ATATCAGGGACTAGAATTTG-3'; second primer, Tm=59, 438C: 5'-GACTGTAGACAAG-GAAACAACAAAGCCTG-3'; third primer, Tm=63, 138C: 5'-TGTAGACAAGGAAACAACAAAGCCTGGT-GGCC-3'.
Recombinant proteins and EMSA
The double Y1-2 56mer contain the following sequences 5'-CAAGCCA GCCAATC AACGTG CAGAAA GGCC TTC-CAGTCTAGCCAATGGGTTGCGCG-3'. Single CCAAT oligonucleotides were: Y1-5'-CAAGCCAGCCAATCAA-CGTGCA-3'-Y2-5'-CAGTCTAGCCAATGGGTTGCGCG -3'-Y3-5'-GCGTCTACCCCAATAGTGCGTC-3'-. Production and puri®cation of NF-YB and NF-YA were described in Mantovani et al. (1992 Mantovani et al. ( , 1994 . Full length NF-YC was derived from PCR using the overlapping clones described in Bellorini et al. (1997) as a starting material. The resulting fragment, containing suitable sites for restriction enzymes at their extremities, was cloned in the PET32b vector (Novagen) into the KpnI and HindIII sites, fused to Thioredoxin, ProtS and two His-tag sequences. The NF-YC gene was entirely sequenced. The protein was produced in BL21(DE3)LysS bacteria. Equimolar amounts of the three subunits from inclusion bodies were renatured and puri®ed on NTA-Agarose (Bellorini et al., 1997) .
Electrophoretic Mobility Shift Assays were performed according to Mantovani et al. (1992) in 4% polyacrylamide gels. Extracts from exponentially growing murine ®broblasts LMTK or human epithelial Hela cells, were prepared according to Viville et al. (1991) . In Figure 6 , the somatostatin promoter CREB-binding oligonucleotide was used. Figure 2 were derived from transfections of exponentially growing NIH3T3 cells (Omega E subtype, from DSMZ, Braunschweig, Germany) with B2-Luci wt and mutant B2-Luci constructs. The quality and quantity of several independent DNA preparations was checked photometrically and visually on agarose gels. All transfections were done as cotransfections with a CMV-driven plasmid expressing Renilla luciferase as internal control to standardize transfection eciencies. Plasmids were transfected by lipofection with 0.5 ml of the Perfect Lipid reagent pFx-6-solution (Invitrogen) with 2.5610 4 normally growing cells per well on a 24-well plate, 1 mg B2-Luci DNA and 20 ng CMV-Renilla vector per well, according to the manufacturer's suggestions. Fire¯y and Renilla luciferase activities were assayed with the Dual Luciferase assay system (Promega). Transfections shown in Figure 2 were repeated 40 ± 80 times with three independent DNA preparations.
Transfections
Data in
Data illustrated in Figure 5 were obtained by cotransfecting exponentially growing NIH3T3 cells (10 6 ) by the calciumphosphate method, using a total of 10 mg of CsCl-puri®ed plasmid DNAs. We used 0.5 mg of B2-Luci target, with the indicated amounts of the YA13m29 dominant negative NF-YA construct (Mantovani et al., 1994) , together with 3 mg of NbGAL as an internal control and various amounts of carrier pGEM plasmid to keep the total DNA concentration constant. After 48 h, extracts were prepared and both bGal and Luciferase assays performed.
